The InnoThyroGen project, in which the Group for Molecular Biomedicine participates on behalf of IMGGЕ, conducts an anonymous survey on personalized medicine.

The InnoThyroGen project is developing new personalized approaches for the diagnosis and treatment of thyroid disease by integrating pharmacogenomics, electronic health records and lifestyle data. The project team is a multidisciplinary consortium of 13 partners from Croatia and Serbia, and the project coordinator is the Faculty of Medicine of the University of Split. The project is funded by the European Commission as part of the HORIZON-WIDERA Excellence Hubs program.